Literature DB >> 6827402

The cellular response to human colonic neoplasms: macrophage numbers.

J M Skinner, L R Jarvis, R Whitehead.   

Abstract

Tumour cells and macrophages are thought to interact and the behaviour of tumours may be modified by macrophage activity. Using an immuno-histochemical method for the demonstration of lysozyme and a computerised image analysis system, the number of macrophages was assessed in and around tubulovillous adenomas and the different Dukes grades of adenocarcinomas of the colon. No significant differences were demonstrated and it is concluded that the behaviour of these neoplasms is not related to the number of associated macrophages.

Entities:  

Mesh:

Year:  1983        PMID: 6827402     DOI: 10.1002/path.1711390202

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  4 in total

1.  Feasibility of new prognostic classification for rectal cancer.

Authors:  S A Dundas; R W Laing; A O'Cathain; I Seddon; D N Slater; T J Stephenson; J C Underwood
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

2.  Lymphocytes infiltrating colorectal cancer have low proliferative capacity but can secrete normal levels of interferon gamma.

Authors:  W J Bateman; I Donnellan; I A Fraser; L S Wong; A G Morris
Journal:  Cancer Immunol Immunother       Date:  1995-07       Impact factor: 6.968

3.  Macrophages and multicellular tumor spheroids in co-culture: a three-dimensional model to study tumor-host interactions. Evidence for macrophage-mediated tumor cell proliferation and migration.

Authors:  S Hauptmann; G Zwadlo-Klarwasser; M Jansen; B Klosterhalfen; C J Kirkpatrick
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

4.  Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect--a histopathological and immunohistochemical study.

Authors:  I D Nagtegaal; C A Marijnen; E K Kranenbarg; A Mulder-Stapel; J Hermans; C J van de Velde; J H van Krieken
Journal:  BMC Cancer       Date:  2001-07-16       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.